Huntington's (I'm not an expert) is a genetic disorder. Although systemic inflammation is like the accelerator in your car and speeds up all processes...It is unlikely to be of great value in Huntington's.
I would suggest you research CRISPR therapeutics. CRISPR holds the possibility of removing hereditary mistakes in the genetic code or adding nucleotide sequences in situations where they are missing...
I can't say this is the answer...but logic suggest it is...
deut8-18, You may be aware of AMRN's failed trial on Huntington's, However, it was "trending" toward effectiveness. The company used what we would say is a very low doseage for that trial. Perhaps at a substantially higher dose Vascepa would have more of an impact on the disease. If I knew of anyone who was at risk for this disease I would encourage them to get on 4 grams of Vascepa per day...and up to 6 grams if they had the disorder. (At least until or unless something proven comes along.) A high school friend of mine died at far too young an age from this...I hope a cure is found.